Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
131.20
+0.48 (0.37%)
At close: Apr 26, 2024, 4:00 PM
131.14
-0.06 (-0.05%)
After-hours: Apr 26, 2024, 7:50 PM EDT
Merck & Co. Revenue
In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth. Revenue in the quarter ending December 31, 2023 was $14.63B with 5.78% year-over-year growth.
Revenue (ttm)
$60.12B
Revenue Growth
+1.40%
P/S Ratio
5.53
Revenue / Employee
$834,931
Employees
72,000
Market Cap
332.28B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
Dec 31, 2019 | 39.12B | -3.17B | -7.50% |
Dec 31, 2018 | 42.29B | 2.17B | 5.41% |
Dec 31, 2017 | 40.12B | 315.00M | 0.79% |
Dec 31, 2016 | 39.81B | 309.00M | 0.78% |
Dec 31, 2015 | 39.50B | -2.74B | -6.48% |
Dec 31, 2014 | 42.24B | -1.80B | -4.08% |
Dec 31, 2013 | 44.03B | -3.23B | -6.84% |
Dec 31, 2012 | 47.27B | -780.00M | -1.62% |
Dec 31, 2011 | 48.05B | 2.06B | 4.48% |
Dec 31, 2010 | 45.99B | 18.56B | 67.66% |
Dec 31, 2009 | 27.43B | 3.58B | 15.00% |
Dec 31, 2008 | 23.85B | -347.70M | -1.44% |
Dec 31, 2007 | 24.20B | 1.56B | 6.90% |
Dec 31, 2006 | 22.64B | 624.10M | 2.84% |
Dec 31, 2005 | 22.01B | -960.90M | -4.18% |
Dec 31, 2004 | 22.97B | 486.90M | 2.17% |
Dec 31, 2003 | 22.49B | 1.04B | 4.85% |
Dec 31, 2002 | 21.45B | 246.80M | 1.16% |
Dec 31, 2001 | 21.20B | -19.16B | -47.48% |
Dec 31, 2000 | 40.36B | 7.65B | 23.38% |
Dec 31, 1999 | 32.71B | 5.82B | 21.62% |
Dec 31, 1998 | 26.90B | 3.26B | 13.80% |
Dec 31, 1997 | 23.64B | 3.81B | 19.21% |
Dec 31, 1996 | 19.83B | 3.15B | 18.87% |
Dec 31, 1995 | 16.68B | 1.71B | 11.43% |
Dec 31, 1994 | 14.97B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 45.81B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
Eli Lilly | 34.12B |
MRK News
- 1 day ago - Merck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Results - Investopedia
- 1 day ago - Merck raises 2024 profit forecast on strong cancer, HPV drugs sales - Reuters
- 1 day ago - Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales - CNBC
- 1 day ago - Merck's first-quarter results beat expectations amid healthy vaccine-sales growth - Market Watch
- 1 day ago - Merck Announces First-Quarter 2024 Financial Results - Business Wire
- 2 days ago - Higher Keytruda Sales To Drive Merck's Q1? - Forbes
- 7 days ago - Cramer's week ahead: Earnings from Tesla, Merck and Big Tech - CNBC
- 22 days ago - Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer - Business Wire